SEC Filings
Hormel Director Sally Smith Will Retire From Board At 2027 Annual Meeting
Smith will not seek re-election, and the company says no disagreement with it prompted her decision.
SEC Filings
Smith will not seek re-election, and the company says no disagreement with it prompted her decision.
SEC Filings
Nasdaq flagged the kidney-drug maker's shares after 30 straight business days below the minimum bid; a reverse stock split is on the table.
SEC Filings
The gold developer added proxy disclosures to head off shareholder demand letters before its vote on buying Paulson's 40% Donlin Gold stake.
SEC Filings
The cancer-drug developer netted about $269.7 million after the underwriters exercised their option in full when the deal closed Friday.
SEC Filings
Lumen moved its top executives into one severance plan and restated the CEO's agreement, saying benefits are not materially changed.
SEC Filings
Freshpet's operations chief keeps her COO job and gets a restricted stock grant that vests in full on June 30, 2029.
SEC Filings
Varga, a Macy's director since 2012, leaves the board December 11, and the company says the exit is not a dispute.
SEC Filings
The drone-parts maker bought Upgrade Energy for shares and $1,000,000 in cash, with up to $26,000,000 more tied to revenue.
SEC Filings
Verbinskaya stays through the 2026 annual report, and the company says her exit involves no disagreement over accounting.
SEC Filings
The casino operator spent $2.50 billion on stock in nine months while profits slipped, and the Board is still raising the dividend.
SEC Filings
Jabil's cash flow rose while inventory and receivables ballooned, because unpaid supplier bills grew by more than $6 billion.
SEC Filings
Integra's 10-Q shows Neurosurgery has a wider 15.3% cushion, and both units stayed above carrying value in a stress test.